Europe Heparin Market, By Product Type (Unfractionated Heparin, Low Molecular Weight Heparin (LMWH), Ultra-Low Molecular Weight Heparin (ULMWH)), Mode of Administration (Oral, Parenteral), Source (Bovine, Porcine), Ingredients (Sodium, Calcium, Others), Availability (Raw, Processed), Treatment (Deep Vein Thrombosis, Pulmonary Embolism, Arterial Thromboembolism, Others), Application (Pre-Surgical Procedures, Post-Surgical Procedures, Kidney Dialysis, Diagnostic Tests, Others), Therapeutics (Cardiovascular, Respiratory, Oncology, Nephrology, CNS, Others), Strength (10 Unit, 100 Unit, 1000 Unit, 5000 Unit, 10000 Unit, 25000 Unit, Others), Type (Generics, Brands), Container (Bottles, Bags, Vials, Others), Packaging (Glass, Plastic), End User (Hospitals, Clinics, Homecare, Ambulatory Surgical Centres, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Drug Store, Online Pharmacy, Others), Country (U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, Ireland, Rest of Europe) Industry Trends and Forecast to 2028.
Market Analysis and Insights : Europe Heparin Market
Europe heparin market is expected to gain market growth in the forecast period of 2021-2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 5.83% in the above mentioned forecast period.
Heparin is a drug that prevents and treats blood clots. It's a drug that's used to treat blood coagulation abnormalities. It's also used to prevent blood from clotting after surgery, during blood transfusions, dialysis, and during taking blood samples. By releasing anti-clotting protein, it aids in the smooth flow of blood. It's referred to as an anticoagulant. It is all treated with the disseminated intravascular coagulation, deep vein thrombosis, pulmonary embolism, and arterial thromboembolism. It does not eliminate blood clots; instead, it prevents them from growing larger and creating more catastrophic complications. Heparin is a substance that comes from the mucosal tissues of killed livestock animals.
The rise in venous thromboembolism and cardiovascular diseases is the major factor influencing the market growth rate. Furthermore, surge in the number of applications of heparin among various surgeries including orthopedic and heart surgeries, growing government support for the improvement of healthcare infrastructure and increase in the demand of surgeries due to the rising geriatric population are the factors that will expand the heparin market. In addition to this, presence of synthetic and semi-synthetic heparin mimetics that are helpful in the treatment of coagulation, cancer and inflammatory disorders will cushion the market growth rate.
Moreover, rise in the research and development activities and growing utilization of sharp-catching label in order to prevent the needle stick injuries will provide beneficial opportunities for the heparin market in the forecast period of 2021-2028.
However, high cost of healthcare and side effects associated with heparin are the factors that will hinder the market growth. Also, presence of alternative anticoagulants will further challenge the heparin market in the forecast period mentioned above.
This Europe heparin market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Europe heparin market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Europe Heparin Market Scope and Market Size
Europe heparin market is segmented on the basis of product type, mode of administration, source, ingredients, availability, treatment, application, therapeutics, strength, type, container, packaging, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product type, the heparin market is segmented into unfractionated heparin, low molecular weight heparin (LMWH) and ultra-low molecular weight heparin (ULMWH).
- On the basis of mode of administration, the heparin market is segmented into oral and parenteral.
- On the basis of source, the heparin market is segmented into bovine and porcine.
- On the basis of ingredients, the heparin market is segmented into sodium, calcium and others.
- On the basis of availability, the heparin market is segmented into raw and processed.
- On the basis of treatment, the heparin market is segmented into deep vein thrombosis, pulmonary embolism, arterial thromboembolism and others.
- On the basis of application, the heparin market is segmented into pre-surgical procedures, post-surgical procedures, kidney dialysis, diagnostic tests and others.
- On the basis of therapeutics, the heparin market is segmented into cardiovascular, respiratory, oncology, nephrology, CNS and others.
- On the basis of strength, the heparin market is segmented into 10 unit, 100 unit, 1000 unit, 5000 unit, 10000 unit, 25000 unit and others.
- On the basis of type, the heparin market is segmented into generics and brands.
- On the basis of container, the heparin market is segmented into bottles, bags, vials and others.
- On the basis of packaging, the heparin market is segmented into glass and plastic.
- On the basis of end-users, the heparin market is segmented into hospital, clinics, homecare, ambulatory surgical centres and others.
- The heparin market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and drug store, online pharmacy and others.
Europe Heparin Market Country Level Analysis
Europe heparin market is analyzed and market size information is provided by the country, product type, mode of administration, source, ingredients, availability, treatment, application, therapeutics, strength, type, container, packaging, end-users and distribution channel as referenced above.
The countries covered in Europe heparin market report are the Germany, France, the U.K, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, and Rest of Europe.
Germany dominates the Europe heparin market due to the presence of major key players, and developing healthcare infrastructure in this region. France and U.K. are expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, and growing prevalence of chronic disorders in this region.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Europe heparin market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Europe Heparin Market Share Analysis
Europe heparin market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Europe presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Europe heparin market research.
The major players covered in Europe heparin market report are F. Hoffmann-La Roche Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Pfizer Inc., Aspen Holdings, Changzhaou Qianhong Bio-pharma Co., ltd., Eisai Co., Ltd., Fresenius Kabi AG, Hebei Changshan Biochemical Pharmaceutical Co. Ltd., Hikma Pharmaceuticals PLC, LEO Pharma A/S, Novartis AG, SARIA A/S GmbH & Co. KG, OPOCRIN S.P.A., Bristol-Myers Squibb Company, GlaxoSmithKline plc., Dr. Reddy’s Laboratories Ltd., B. Braun Melsungen AG, Baxter, among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.